Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

590
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
590

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Landscape of Prostate Tumour Methylation.

Cancer discovery·2026
Same author

Reply to Dr. Vadhithala's Letter to the Editor re: Marc A. Furrer, Benjamin Lyttwin, Michael S. Pärli, et al. Incidental Prostate Cancer Is an Uncommon but Clinically Non-negligible Cause of Death in Selected Long-term Survivors of Urothelial Carcinoma-Oncological Outcomes and a Proposed Follow-up Strategy from a Tertiary Referral Center. Eur Urol Open Sci 2026;86:10-9.

European urology open science·2026
Same author

International Multicentre Analysis of Perioperative Complications Following Major Urologic Oncologic Surgery: Early Results from More than 130 000 Procedures from the CAMUS Collaborative.

European urology focus·2026
Same author

The CAMUS Initiative: A Multiphase, Multicentre International Collaboration to Redefine Risk Stratification, Reporting, and Grading of Surgical Complications in Urology.

European urology open science·2026
Same author

Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature.

Cell reports. Medicine·2026
Same author

The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection.

BJU international·2026
Same journal

The external clinical teaching visit: GP supervisor engagement and perceptions of utility.

Australian journal of general practice·2026
Same journal

Time to re-examine penicillin allergy in Australian general practice.

Australian journal of general practice·2026
Same journal

No place like home: The role of general practitioners in a housing crisis.

Australian journal of general practice·2026
Same journal

Expanding Medicare access for treating opioid dependence.

Australian journal of general practice·2026
Same journal

How to thrive in general practice training: A practical guide.

Australian journal of general practice·2026
Same journal

The VETERANS lens: A new tool to enhance consultations with veteran patients.

Australian journal of general practice·2026
See all related articles

Related Experiment Video

Updated: Dec 25, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

558

Advances in prostate cancer.

Fairleigh A Reeves1, Niall M Corcoran2

  • 1MBBS, PhD, Urology Trainee, Austin Hospital, Vic.

Australian Journal of General Practice
|April 2, 2020
PubMed
Summary
This summary is machine-generated.

Recent advancements in prostate cancer diagnosis and management, including new imaging techniques and combination therapies, have significantly improved patient outcomes. These updates are crucial for general practitioners managing prostate cancer in Australian men.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.0K

Related Experiment Videos

Last Updated: Dec 25, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

558
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.0K

Area of Science:

  • Oncology
  • Urology
  • General Practice

Background:

  • Prostate cancer is a prevalent cancer among Australian men.
  • General practitioners play a vital role in prostate cancer diagnosis and management.

Purpose of the Study:

  • To review significant advancements in prostate cancer diagnosis and management over the last five years.
  • To highlight changes relevant to general practice.

Main Methods:

  • Review of recent literature and clinical guidelines.
  • Analysis of emerging diagnostic and therapeutic strategies.

Main Results:

  • Introduction of routine prostate magnetic resonance imaging (MRI) in diagnosis.
  • Increased use of prostate-specific membrane antigen positron emission tomography (PSMA PET) for staging and salvage therapy.
  • Improved survival rates in metastatic prostate cancer through combination therapies (androgen deprivation therapy + systemic treatments).
  • Growing recognition of germline DNA repair defects and targeted therapy potential.

Conclusions:

  • Prostate cancer diagnosis and management have undergone substantial evolution in the past five years.
  • New clinical pathways and technologies are transforming patient care.
  • These changes necessitate updated knowledge for healthcare professionals, especially general practitioners.